We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+2.05%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$101B
AUM Growth
+$37.4B
Cap. Flow
+$36.7B
Cap. Flow %
36.22%
Top 10 Hldgs %
21.17%
Holding
5,633
New
1,585
Increased
2,056
Reduced
1,281
Closed
669

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Consumer Discretionary 5.03%
3 Financials 3.61%
4 Healthcare 3.25%
5 Industrials 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXSQ icon
4901
Oxford Square Capital
OXSQ
$151M
$27K ﹤0.01%
11,085
-650
-6% -$1.79K
BTAI icon
4902
BioXcel Therapeutics
BTAI
$26.2M
$26.9K ﹤0.01%
4,503
+3,021
+204% +$25.2K
NKLA
4903
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
$26.7K ﹤0.01%
+22,400
New +$64K
APPS icon
4904
PUT
Digital Turbine
APPS
$1.02B
$26.5K ﹤0.01%
+15,700
New +$34.9K
BOLT icon
4905
Bolt Biotherapeutics
BOLT
$7.36M
$26.2K ﹤0.01%
+2,449
New +$29.6K
EPIX
4906
DELISTED
ESSA Pharma
EPIX
$26K ﹤0.01%
+14,525
New +$46.3K
CREX icon
4907
Creative Realities
CREX
$41.9M
$25K ﹤0.01%
+10,191
New +$37.6K
FRGE
4908
CALL
DELISTED
Forge Global Holdings
FRGE
$24.9K ﹤0.01%
+1,787
New +$29.4K
ALEC icon
4909
Alector
ALEC
$164M
$24.8K ﹤0.01%
+13,114
New +$49.4K
MJ icon
4910
PUT
Amplify Alternative Harvest ETF
MJ
$101M
$24.2K ﹤0.01%
+900
New +$30.1K
OTLY
4911
Oatly Group
OTLY
$417M
$23.1K ﹤0.01%
+1,746
New +$25.7K
IXHL icon
4912
Incannex Healthcare
IXHL
$35.3M
$22.7K ﹤0.01%
357
-14
-4% -$841
SGMO
4913
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$22.3K ﹤0.01%
+21,900
New +$40K
DUO
4914
Fangdd Network Group
DUO
$21.9M
$21.6K ﹤0.01%
+2,258
New +$38.7K
ANY icon
4915
Sphere 3D
ANY
$14.6M
$21.6K ﹤0.01%
+2,284
New +$26.6K
CUE icon
4916
Cue Biopharma
CUE
$135M
$21.5K ﹤0.01%
+656
New +$24.7K
CODX
4917
Co-Diagnostics
CODX
$7.74M
$21.3K ﹤0.01%
+945
New +$29.8K
FLUX icon
4918
Flux Power
FLUX
$12.6M
$20.9K ﹤0.01%
+13,252
New +$31.4K
BDSX icon
4919
Biodesix
BDSX
$228M
$20.7K ﹤0.01%
+676
New +$19.9K
SOL
4920
DELISTED
Emeren Group
SOL
$20.4K ﹤0.01%
+10,055
New +$22.2K
ABOS icon
4921
Acumen Pharmaceuticals
ABOS
$154M
$20.3K ﹤0.01%
+11,815
New +$28.4K
BLNK icon
4922
PUT
Blink Charging
BLNK
$75.2M
$20.2K ﹤0.01%
+14,500
New +$25.6K
BTOG icon
4923
Bit Origin
BTOG
$2.23M
$19.5K ﹤0.01%
+332
New +$32K
CODX
4924
CALL
Co-Diagnostics
CODX
$7.74M
$18.9K ﹤0.01%
+840
New +$26.5K
PACB icon
4925
Pacific Biosciences
PACB
$422M
$18.6K ﹤0.01%
10,178
-32,862
-76% -$64.1K

Similar funds

Squarepoint's Q4 2024 Portfolio in Review

As of Q4 2024, Squarepoint held 5,633 positions worth $101B, up 59% from $63.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Squarepoint deployed $36.7B of net new capital in Q4 2024, opening 1,585 new positions and adding to 2,056 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $2.67B trimmed.

  • Squarepoint's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
  • Squarepoint added most to NVIDIA in Q4 2024, an estimated $1.29B increase.
  • Squarepoint's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.67B.
  • Squarepoint fully exited State Street Financial Select Sector SPDR ETF in Q4 2024, selling an estimated $86.3M.
  • Squarepoint's ten largest holdings make up 21% of its $101B portfolio in Q4 2024.
  • Squarepoint opened 1,585 new positions and closed 669 in Q4 2024.
  • Squarepoint's portfolio value rose 59% quarter-over-quarter to $101B.

Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.